Back to search
FDAFDA · Food and drugs·Recall number Z-2549-2026

Hillrom VOLARA P.CIRCUIT 5KIT (System Single Patient Use Circuit), Model/Catalog Number REF M08270; Oscillation Lung Expansion Therapy, positive pressure breathing device

Published July 8, 2026 · Recall initiated: May 21, 2026

Summary

FDA records medical device Class I recall Z-2549-2026, published July 8, 2026 and initiated May 21, 2026. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 0; Lot: UDI: 10887761985015; Lot Numbers: All lot numbers distributed beginning on 4/28/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There have been reports of air and medication leakage from the nebulizer cup during therapy of Volara system patient circuits. The leakage can lead to an oxygen level drop in the patient and ineffective nebulization, which may affect the delivery of the prescribed treatment. The issue has been associated with improper locking of the nebulizer cup after adding medication during user setup.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corporation
Distributor
Worldwide distribution - US Nationwide and the country of Canada.
Lot
UDI: 10887761985015; Lot Numbers: All lot numbers distributed beginning on 4/28/2025
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Hillrom VOLARA P.CIRCUIT 5KIT (System Single Patient Use Circuit), Model/Catalog Number REF M08270; Oscillation Lung Expansion Therapy, positive pressure breathing device recalled?

Yes. FDA published recall Z-2549-2026 on July 8, 2026. Reported hazard: There have been reports of air and medication leakage from the nebulizer cup during therapy of Volara system patient circuits. The leakage can lead to an oxygen level drop in the patient and ineffective nebulization, which may affect the delivery of the prescribed treatment. The issue has been associated with improper locking of the nebulizer cup after adding medication during user setup.

What should I do if I have this product?

Voluntary: Firm initiated · Letter